Queen Elizabeth Hospital, Birmingham, B15 2WB, UK.
King's Mill Hospital, Sutton-In-Ashfield, NG17 4JL, UK.
Breast Cancer. 2022 Nov;29(6):945-956. doi: 10.1007/s12282-022-01387-5. Epub 2022 Jul 17.
Breast surgeries are an increasingly frequent operation, with an exponential rise in breast cancer diagnoses, and women opting for cosmetic surgeries. SSIs are the most common post-operative complication with many negative consequences including sepsis and even death. These are treated with prophylactic antibiotics prior to surgery. Breast surgery is currently defined as 'clean', although literature indicates that the infection rate is higher than should be expected for this classification. The aim of this meta-analysis is to evaluate whether pre-operative antibiotics reduce SSI frequency and which class of antibiotics achieve the best reduction.
A literature search through online libraries was used to find clinical trials investigating pre-breast-surgery antibiotics and SSI frequency. These were grouped all together and separately by class of antibiotics. Additionally studies investigating breast cancer surgeries and non-cancer surgeries were grouped separately. A forest-plot was created for each group to calculate an estimated effect, these were then compared against each other.
Use of antibiotics resulted in a reduction in SSI frequency by 3.55% overall, and reduced frequency in all types of surgeries performed. Cephalosporins reduced SSI frequency by 2.23%, Beta-lactamase inhibitors 4.17% and macrolides achieved the greatest effect with a 14.58% reduction.
This meta-analysis proves that antibiotics reduce SSI frequency in breast surgery and supports the notion to remove the 'clean' classification. This definition may result in failure to provide prophylaxis, resulting in patients suffering from preventable SSIs and their negative consequences. Macrolides were the most effective followed by beta-lactamase inhibitors and cephalosporins, this may be implemented in structuring new guidelines favouring use of macrolides before conducting breast surgery.
乳房手术是一种越来越常见的手术,随着乳腺癌诊断的指数级增长,越来越多的女性选择进行美容手术。手术部位感染(SSI)是最常见的术后并发症,其后果包括败血症,甚至死亡。这些并发症在手术前使用预防性抗生素进行治疗。乳房手术目前被定义为“清洁”手术,尽管文献表明其感染率高于该分类所预期的水平。本荟萃分析旨在评估术前使用抗生素是否能降低 SSI 发生率,以及哪种类型的抗生素能达到最佳的降低效果。
通过在线图书馆进行文献检索,以查找研究术前使用抗生素和 SSI 发生率的临床试验。这些研究被全部归为一组,并根据抗生素的类别分别分组。此外,还将研究乳腺癌手术和非癌症手术的研究分别分组。为每组创建一个森林图以计算估计效果,然后将它们相互比较。
抗生素的使用使 SSI 发生率总体降低了 3.55%,并降低了所有类型手术的 SSI 发生率。头孢菌素降低 SSI 发生率 2.23%,β-内酰胺酶抑制剂降低 4.17%,而大环内酯类药物的效果最大,降低了 14.58%。
本荟萃分析证明抗生素可降低乳房手术中的 SSI 发生率,并支持取消“清洁”分类的观点。这种定义可能导致未能提供预防措施,使患者遭受可预防的 SSI 及其不良后果。大环内酯类药物最有效,其次是β-内酰胺酶抑制剂和头孢菌素,这可能有助于制定新的指南,在进行乳房手术前优先使用大环内酯类药物。